Targeting Autophagy in Multiple Myeloma
Apoptosis (Type I) and autophagy (Type II) represent two major forms of programmed cell death. Numerous anticancer agents employed in standard chemotherapy or novel targeted therapy induce both apoptosis and autophagy. Of note, a cytoprotective autophagic response often counteracts apoptosis trigger...
Main Author: | Dai, Yun |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2015
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/3933 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=4953&context=etd |
Similar Items
-
iNOS Interacts with Autophagy Receptor p62 and is Degraded by Autophagy in Macrophages
by: Jing Wang, et al.
Published: (2019-10-01) -
The Autophagy Regulator p62 Controls PTEN-Dependent Ciliogenesis
by: Hyowon Mun, et al.
Published: (2020-06-01) -
Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
by: Sheng Wang, et al.
Published: (2021-03-01) -
SP600125 enhances C-2-induced cell death by the switch from autophagy to apoptosis in bladder cancer cells
by: Haiyang Yu, et al.
Published: (2019-11-01) -
Degradation of the Tumor Suppressor PDCD4 Is Impaired by the Suppression of p62/SQSTM1 and Autophagy
by: M. Manirujjaman, et al.
Published: (2020-01-01)